BCL2 and neoplasm: MAT2A overexpression in liver and colon cancer increases tumor survival and chemo-resistance, by a mechanism involving B-cell lymphoma 2 (BCL-2) transcription, acting directly as a transcription factor that transactivates the BCL-2 promoter, and also stabilizing the BCL-2 protein [126].